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OP037
CASE STUDY: VOICE OF TOBACCO VICTIMS SUCCESS WITH INDIAN DENTAL
ASSOCIATION
Kunal Oswal 1, Ashima Sarin 1, Pankaj Chaturvedi 2. 1Healis-Sekhsaria Institute
for Public Health, India; 2Tata Memorial Hospital, India
Background: Voice of Tobacco Victims (VoTV) is a campaign lead by patients and
their families who share their heart wrenching stories with the policy makers.
The doctor who has treated the patient is also part of the platform, one to
reassure the victim and second to provide clinical support for the statement
made by the victims. In the VoTV, doctors are often referred as patrons. The
victims not only present their story and the impact tobacco had on their lives,
they also advocate for adoption of and implementation of effective tobacco
control policy. To curb this menace it is necessary to mobilise the key stake-
holder so as to have strong lobby while doing advocacy with policy makers or
key stakeholders.
Objective: The objectives were to involve the professional body like Indian
Dental Association to be a part of the campaign and make its presence felt.
Method: VoTV networked and got associated with the Indian Dental Association.
The professional association are representatives nationally with branches at
state and local level all over India. Liaising with such body proved to be vital
to garner support for lobbying with policy makers for effective tobacco control
at local, state and national level
Result: Indian Dental association of Uttarpradesh and Assam filed a Public
Interest Litigation for the Gutka Ban in the respective state. Furthermore it
also became party in the Ankur Gutka case. IDA through its state branch partic-
ipated in the VoTV chapter of Bihar. IDA at national level launched a campaign
addressing the prime minister to ban packaged and flavoured smokeless tobacco
product. In Maharashtra, results shared with the high court on the prevalence
of oral submucous fibrosis were taken into account while fighting for gutka and
pan masala ban.
Conclusion: Involving key stakeholders like dentist through IDA is vital for ad-
vocacy campaign. The professional body represent the society and their voice
put a lot of pressure on policy makers where there is lax in implementation of
policy
Beyond cigarettes: smokeless tobacco, ENDS (electronic
nicotine delivery system)
OP005
PERCEPTIONS OF TEXT AND PICTORIAL HEALTH WARNINGS FOR SMOKELESS
TOBACCO IN INDIA AND BANGLADESH
Prakash C. Gupta 1, Seema Mutti 2, Nigar Nargis 3, Jessica L. Reid4,
Hemlata Shedge1, David Hammond2. 1Healis-Sekhsaria Institute for Public
Health, India; 2University of Waterloo, Canada; 3University of Dhaka,
Bangladesh; 4Propel Centre for Population Health Impact, Canada
Background: India and Bangladesh have more smokeless tobacco (SLT) users
than the rest of the world combined. Health warnings on packages are among
the most cost-effective means to communicate the health effects of tobacco
use, which remains a priority for tobacco control policy. India was the first
country in the world to implement pictorial warnings for SLT packages; no
warnings are required on products in Bangladesh. There is little evidence on
the efficacy of warnings in India, and very limited research in general to guide
regulators in low and middle-income countries on selecting content.
Objective: This study sought to 1) develop the evidence base for more effective
health warnings for SLT packages in India and Bangladesh, and 2) assess patterns
of use and perceptions of risk about SLT.
Method: An experimental study was conducted in India (n=1,002) and
Bangladesh (n=1,081), with adult SLT users, and youth users and non-users.
Respondents were randomly assigned to view 5 SLT health warnings for 5 differ-
ent health effects according to one of four experimental conditions: 1) text-only
warning, 2) pictorial warning with symbolic imagery, 3) pictorial warning with
a graphic health effect, or 4) pictorial warning with a personal testimonial.
Result: Awareness of health warnings on packs was higher in India than in
Bangladesh. A majority (89%) of adult and youth SLT users in India and
Bangladesh reported daily use. SLT users in India reported greater quit in-
tentions than users in Bangladesh (p<0.001). Respondents were more likely
to report “less harm” (54%) as the primary reason for selecting their “usual
product”. Indian respondents were more likely to believe that SLT was more
harmful than cigarettes (66.5%) or bidis (70.2%), compared to Bangladeshi re-
spondents (50.0%, p<0.001; 50.4%, p<0.001). Text-only warnings were rated as
less effective than all of the pictorial warnings (p<0.001 for all). Among picto-
rial warnings, graphic health effects were rated as most effective, followed by
personal testimonials, and symbolic imagery (p<0.001 for all contrasts). More
than three-quarters of respondents in India reported that SLT packs should have
more health information, and 80% in Bangladesh believe that packs should have
health warnings.
Conclusion: False health beliefs about smokeless tobacco are common in India
and Bangladesh. There is strong evidence for the efficacy of graphic pictorial
health warnings and strong support among users for their implementation.
OP018
THE RISE OF E-CIGARETTES: AN EMERGING THREAT TO THE TOBACCO
ENDGAME?
Angela Pratt 1, Laura Su2, Carmen Audera-Lopez2, James Rarick2,
Susy Mercado2. 1WHO China Office, Beijing, Chine; 2WHO, Western Pacific
Region Office, Manila, Philippines
Background: Electronic cigarettes (e-cigarettes) first developed in China in
2004are gaining popularity and the number of e-cigarette users is growing
rapidly. E-cigarette manufacturers and supporters of the devices argue that
e-cigarettes are a safe alternative to tobacco smoking, and that they may aid
smoking cessation. However, there is currently insufficient scientific evidence
to prove their safety and efficacy. Furthermore, at the 5th session of the WHO
FCTC Conference of Parties, concerns were raised that ENDs have been aggres-
sively advertised and marketed as imitation or substitute tobacco products and
as cessation devices around the world. Parties called for WHO to gather more
evidence on whether e-cigarettes are safe, their efficacy as cessation aids, and
that they don' t act as a gateway to nicotine addiction for young people.
Objectives: The objective of this paper is to discuss health concerns on e-
cigarettes and to provide an overview of recent responses and regulations
made by governments to ensure protection from potential health threats to
individuals and populations. It will also examine the different marketing strate-
gies employed by manufacturers in order to highlight the need for regulation
of these products.
Methodology: Systematic review of existing online information.
Results: This paper consolidates existing information and evidence and outlines
priorities for research and policy development.
OP027
THROUGH THE SMOKE-SCREEN: EMPOWERING YOUTH TO SPEAK AGAINST
SHISHA SMOKING
Vasuki Utravathy, Aurelia Ong, Vijayalakshimi Karupiah. Health Promotion
Board, Singapore
Background: The first shisha outfit was set up in 2001 and in a decade, there
are about 43 outlets all around Singapore. Shisha has a disproportionate traction
among Singapore residents, especially among those aged 18–39 years. IT is also
rising in popularity among non-cigarette smoking youth.
Objective: The disproportionate use and favourable view of shisha among the
youths and young adults is of concern as international studies have shown that
shisha smoking is a potential gateway drug for youth, who will progress to
cigarette smoking in future and even become dual user (i.e. regular users of
shisha and cigarettes).
Method: In March 2012, HPB strengthened its public education measures with
its first-ever targeted public education campaign reaching out to the patrons
of the shisha café to increase awareness on the health risks associated with
shisha smoking. Measures adopted included a geo-targeted MMS clip as well
as presence of youth advocates engaging peers in discussions on ill-effects of
shisha smoking.
Result: Three weeks post-campaign, 214 respondents (including 88 shisha smok-
ers) were interviewed on the effectiveness of the campaign in raising awareness
on the harms of shisha smoking. 87% of the respondents recalled the key mes-
sage of the campaign correctly and 60% of non-shisha smokers mentioned that
they would refuse to smoke shisha in the future. 20% of them also mentioned
that they will inform their friends and family who smoke shisha about the harms
of the product and discourage them from doing so.
Conclusion: Creative campaigns and engagement of trained peer advocates
can have the unintended consequence of disseminating, especially in this age
of social media.
OP029
SELF-REPORTED TOBACCO USE AND 24-HOUR URINARY COTININE LEVELS IN
RURAL GOA
Preet Kaur Dhillon1, Ruby Gupta 1, Dilip Jha 1, Amit Dias 2, Vikram Patel 2,
Sherin Abraham2, Shah Ebrahim1. 1South Asia Network for Chronic Disease,
PHFI, New Delhi, India; 2Sangath, Goa, India
Background: In India, tobacco is consumed in various forms, and in recent
years, smokeless tobacco has become more common than cigarette or beedi
smoking (Rani M et al, 2003, Dhawan P et al, 2009). Cotinine, a stable metabo-
lite of nicotine, is considered the best biomarker of tobacco consumption and
can be measured from saliva, blood or urine samples.
Objective: As part of a community-based study on chronic diseases and risk
factors in rural Goa, we assessed 24-hour urinary cotinine levels to validate
self-reported tobacco habits in a group of 98 men and women classified as non-
users (20%), cigarette smokers (24.2%), passive smokers (15.8%) and tobacco
chewers (40%).
Method: Demographic, lifestyle, risk factor and anthropometric data were col-
lected via interviewer-administered standardized questionnaires. 24-hour urine
samples were collected starting after the first morning' s void, stored in steril-
ized, two-liter containers at –200°C, and transported to the SANCD, PHFI/CCDC
Genetics and Biochemistry Laboratory, New Delhi for analysis. Cotinine was
estimated using kits from Calbiotech Inc, CA 91978.
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T-tests and multivariate linear regression models were conducted to compare
cotinine levels between comparison groups.
Result: Males and females were equally represented, with a mean age of
45.8 yrs (SD=12.6 years). Cigarette smokers had significantly higher co-
tinine levels (1477.4±1602 ng/ml) than non-smokers (57.6±155.2 ng/ml,
p=0.02), and passive smokers (spouses of smokers) levels were intermedi-
ate (940.6±1719 ng/ml). Tobacco chewers had the highest cotinine levels of
all groups (2779.9±2591 ng/ml) and the significant difference persisted after
adjustment for age, sex, body mass index, and physical activity (p
Conclusion: This is one of the first studies evaluating cotinine levels for
smokeless tobacco in 24-hour urine samples in India. These findings require
replication and suggest that combating nicotine dependency in chewers may be
more difficult than in other tobacco users.
OP032
ARE INDIANS SHIFTING FROM SMOKING TO SMOKELESS TOBACCO?
G.K. Mini 1, N.B. Sureshkumar2. 1Sree Chitra Tirunal Institute for Medical
Sciences and Technology, Trivandrum, India; 2State Resource Centre,
Trivandrum, India
Background: Smoking is the dominant form of tobacco globally. However in
Asian countries like China, India and Indonesia which share the maximum bur-
den of tobacco use, the use of smokeless form of tobacco is common. The
adverse health and economic effect of smokeless tobacco is as harmful as that
of smoking. In India, 75% of the tobacco users were smokeless tobacco users
(SLT). Limited information is available at the population level on smokeless
tobacco as a smoking cessation aid in India.
Objective: The present study examines the tobacco transition with specific em-
phasis on switching over to smokeless tobacco as a smoking cessation method
among adults in India.
Method: We used raw data on the nationally representative household survey
Global Adult Tobacco Survey (GATS) 2009–2010 India for the present study. We
studied the smoking cessation method for those who quit smoking within 1 year.
Result: Prevalence of smokeless tobacco was nearly two times higher than that
of smoking in India. The exclusive smokeless tobacco use was three time high
than that of smoking prevalence. Quit ratio was low among smokeless tobacco
users (5%) compared to smokers (13%). SLT use was more prevalent in rural
area (29%) compared to their urban counterparts (18%). Among former smokers
(ever-smokers who stopped smoking within one year) 20% switched to smokeless
tobacco as a smoking cessation method. Men were five times higher switching
to SLT than women (OR 4.81, 95% CI 4.76–4.87). Youth (15–24 years) (OR 1.59,
CI 1.57–1.60) educated (OR 4.14, CI 4.11–4.17) and employed (OR 10.8, CI
10.66–10.94) adults were more likely to switching to smokeless tobacco as a
smoking cessation aid.
Conclusion: The recent transition from smoking to smokeless tobacco use in
India is remarkable and relevant to the global discussion for further studies
and has implications for tobacco control policies in India. The low quit rate
among smokeless tobacco users and a high proportion of smokers switching to
smokeless tobacco predicts the future burden of SLT in India.
OP033
A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE HEALTH EFFECTS OF
NON-SNUS SMOKELESS TOBACCO PRODUCTS
Sudhir Venkatesan1, Jo Leonardi-Bee1, Puja Myles 1, Ann McNeill 2.
1University of Nottingham, United Kingdom; 2King' s College London, United
Kingdom
Background: Previous reviews on the health effects of smokeless tobacco
have included Swedish snus, which is known to be less harmful than conven-
tional products, and preparations containing betel nut which is independently
carcinogenic.
Objective: This systematic review seeks to determine risk of oral squamous
cell carcinoma (OSCC), leukoplakia, periodontal disease, pancreatic cancer
and adverse foetal outcomes in users of non-snus smokeless tobacco products
(NSST).
Method: Systematic review and meta-analysis was conducted in accordance
with Meta-analysis of Observational Studies in Epidemiology (MOOSE) guide-
lines. Pooled odds ratios and 95% confidence intervals were estimated by
using random-effect models. We searched Medline, Embase and PsycInfo; no
language restrictions were imposed. The primary outcomes were OSCC, leuko-
plakia, periodontal disease, pancreatic cancer and adverse foetal outcomes.
All forms of smokeless tobacco from different countries, except snus and the
ones containing betel nut, were considered as exposures.
Result: A total of 25 studies from 7 different countries were included, of which
19 could be included in the meta-analysis. NSST was significantly associated
with an increased risk of leukoplakia (OR=13.46; 95% CI: 4.29 to 42.25; I2=98%)
and nearly doubled the risk of OSCC (OR=1.84; 95% CI: 0.83 to 4.07; I2=95%).
However, NSST use had no significant effect on the risk of pancreatic cancer
(OR=1.04; 95% CI: 0.47 to 2.32; I2=59%). Adverse fetal outcomes were only
considered in one study which found that NSST use during pregnancy decreased
mean birth weight of the infant by 17.1g (95% CI: 103 to 69). It was not possible
to calculate pooled estimates for studies considering periodontal disease due
to insufficient data.
Conclusion: NSST users are at significantly increased risk of OSCC and leuko-
plakia however no association was detected with pancreatic cancer. Few stud-
ies have been performed on other systemic diseases, in particular relating to
pregnancy outcomes. The findings of this meta-analysis reaffirm the vastly
heterogeneous nature of smokeless tobacco products around the world. Despite
the exclusion of potential confounding factors (South Asian products containing
betel nut) and products with markedly different manufacturing processes (snus
from Sweden), extreme levels of heterogeneity were observed which makes
it critical for future global research on smokeless tobacco to identify a firm
means of classifying and assimilating evidence on smokeless tobacco.
OP039
SURVEILLANCE OF OTHER TOBACCO PRODUCT USE IN THE ASIA–PACIFIC
REGION: IMPLICATIONS FOR POLICY
S. Benjakul, P. Gupta, A.Z. Khan, M. Kashiwabara, S. Kosen, J.R. Rarick,
D.N. Sinha, H. Tee Guat Hiong, M. Zaman. WHO, Western Pacific Region Office
Background: The WHO South-East Asia and Western Pacific Regions have a
combined 680 million tobacco smokers, and within the South-East Asia Region
alone there are an additional 250 million smokeless tobacco users. Many coun-
tries have started to implement effective tobacco demand reduction measures.
However, as countries enforce smoke-free legislation, and raise tobacco taxes
(focussing in most cases on manufactured cigarettes) tobacco companies have
started to shift to marketing smokeless tobacco products and/or other forms of
tobacco not affected by the increase of prices.
Objectives: To describe prevalence of use, market-size, and cost of “other
tobacco products” relative to manufactured cigarettes in eight countries that
have conducted the Global Adult Tobacco Survey.
Methodology: This study examines findings from Global Adult Tobacco Surveys
conducted in eight countries (Bangladesh, China, India, Indonesia, Malaysia,
Philippines, Thailand, and Vietnam) to determine the prevalence of a variety
of other tobacco product use (defined and non-manufactured cigarettes). Re-
cent trends in market growth of other tobacco products, along with price and
taxation data, were also analysed where this information was available.
Results: While the types of other tobacco product use varies between coun-
tries, prevalence of use of these products represents a significant proportion
of overall tobacco use in several of the countries studied. Analyses of avail-
able tax data has shown that several of the products looked at were taxed at
significantly lower rates than manufactured cigarettes.
Conclusions: Other tobacco product use represents a significant portion of
the tobacco-related health burden in several countries in South-East Asia. The
findings of this study point to a need for improved surveillance to better identify
trends in the use of other tobacco products, and for policies to reduce demand
for these products.
The political landscape for the tobacco endgame
OP001
REGULATING INDUSTRY INTERFERENCE & WHO FCTC IMPLEMENTATION:
ARTICLE 5.3 & THE FUTURE OF GLOBAL HEALTH
Jeff Collin, Sarah Johnston, Evgeniya Plotnikova, Sarah Hill. University of
Edinburgh, United Kingdom
Background: Unlike other producers of unhealthy commodities, tobacco com-
panies are now widely viewed as vectors of disease, with whom partnership
approaches are recognised as unacceptable in policy and in science and from
whom voluntary initiatives are seen as inadequate. The fundamental conflict of
interest between the tobacco industry and health receives unique recognition
in Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC),
under which states must protect the development of public health policies from
tobacco industry interference. Yet the extent to which parties are committed
to implementing Article 5.3 can appear questionable.
Method: We examined FCTC implementation reports from 161 countries to
assess country perceptions of the extent of implementation of Article 5.3 and
of tobacco industry interference as a barrier to FCTC implementation.
Result: Overall, 54% of FCTC parties report having adopted and implemented
programmes to protect tobacco control policies from the vested interests of
the tobacco industry. This figure masks substantial variation when countries
are organized by World Bank income categories; only one third of low income
countries and under half of high income countries report implementing such
programmes. Variation is more pronounced across WHO regions; whereas al-
most three quarters of countries from the Eastern Mediterranean Region claim
to have implemented such measures, almost two thirds of the African Region
report no such progress. Fewer countries claim to have implemented measures
to ensure public access to information on industry activities; three quarters of
both low- and high-income countries report no such measures. Comments pro-
vided within the implementation reports suggest low compliance with specific
recommendations made in the implementation guidelines for Art. 5.3. Only
9 countries identified Art. 5.3 as a priority for further FCTC implementation,
while one fifth of parties identified tobacco industry interference and tactics
as barriers to implementation more broadly.
Conclusion: The successful implementation of Art. 5.3 is widely recognised
